Prognostic-disability Biomarkers in Multiple Sclerosis: Review of the Literature from the Last Five Years/Multipl Skleroz Olgularinda Prognoz-Ozurluluk Biyoisaretcileri: Son Bes Yila Ait Literaturun Gozden Gecirilmesi

With the advent of new agents in the treatment of multiple sclerosis, new treatment modalities have emerged (escalation-induction therapy) and the increased efficacy of the drugs has led to increased drug-related risks. The risk/benefit balance has become more carefully assessed. The increased need...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Türk nöroloji dergisi 2018-09, Vol.24 (3), p.203
1. Verfasser:	Kiylioglu, Nefati
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological markers Care and treatment Disabilities Multiple sclerosis Prognosis Risk factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!